Company / Operating Cash Flow per Share
Cocrystal Pharma, Inc. Operating Cash Flow per Share History
FY2012-FY2021 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$0.18
FY2021
5-year range
-$0.28 / -$0.03
FY2017-FY2021
Trend
-306.1%
vs FY2020
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Cash Flow per Share changed -306% YoY in FY2021, a notable deviation from the 3-year average annual change of -361%.
Based on SEC 10-K filings.
-0.18 in FY2021.
Improved from $-0.28 to $-0.18 over the past 2 years.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2021, operating cash flow per share decreased 306.1% year-over-year.
Company context
Key Data Points
- Altman Z-Score 14.87 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2021 | -$0.18 | -306.1% |
| FY2020 | -$0.04 | +83.9% |
| FY2019 | -$0.28 | -861.7% |
| FY2012 | -$0.03 | - |
As of FY2021 · SEC 10-K · Updated Jun 24, 2026